VIRPAX PHARMACEUTICALS INC (VRPX)
US9282512063 - Common Stock
Stay updated with the stocks that are on the move in today's pre-market session.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Stay updated with the stocks that are on the move in today's pre-market session.
Get insights into the top gainers and losers of Tuesday's pre-market session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Top movers in Monday's pre-market session
Monday's pre-market session: top gainers and losers
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
Virpax Pharmaceuticals just reported results for the second quarter of 2024.
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virpax Pharmaceuticals (NASDAQ:VRPX) just reported results for the second quart...
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Virpax Regains Compliance with Nasdaq Minimum Bid Price
Why Is Hawaiian Electric (HE) Stock Up 15% Today?
Hawaiian Electric stock is up on Wednesday after HE investors learned of a reported settlement tied to the 2023 Maui fires.
PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update
Plug Power stock is up on Wednesday after the company provided investors with an update on its hydrogen refueling stations in Europe.
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?
Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company.
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?
Virpax Pharmaceuticals stock is up on Wednesday as VRPX shareholders celebrate successful results from a swine model study.
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
Wednesday, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) released results for a Swine Model pilot study for Probudur, Virpax’s long-acting liposomal bupivacaine formulation injected at a wound site to provide immediate and extended pain relief. Shares are trading on a strong session volume of over 100 million, as per data from Benzinga Pro. The pharmacokinetics (PK) and safety study of Probudur in the Swine Model was designed to determine the PK profile of Probudur and to ascertain any adverse effect
Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares.
Why Is HilleVax (HLVX) Stock Down 87% Today?
HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants.
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 97% Today?
Virpax Pharmaceuticals stock is up on Monday as VRPX investors react to new funding and changes to the company's board of directors.
